This document provides a critical review of the current "cost-benefit analysis tool" used in the health sector. It argues that this tool values human lives differently based on their income level and country, seeing lives in richer countries as more valuable than lives in poorer countries. This is because the tool calculates the monetary value of a statistical life based on people's "willingness to pay" to reduce their mortality risk, which is determined by their ability to pay rather than true willingness. The document proposes using a "percentage willingness to pay" model instead to address this issue and allow poorer people's lives to be valued equally rather than less.